Cargando…

Development and Characterization of Recombinant Ovine Coagulation Factor VIII

Animal models of the bleeding disorder, hemophilia A, have been an integral component of the biopharmaceutical development process and have facilitated the development of recombinant coagulation factor VIII (fVIII) products capable of restoring median survival of persons with hemophilia A to that of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zakas, Philip M., Gangadharan, Bagirath, Almeida-Porada, Graca, Porada, Christopher D., Spencer, H. Trent, Doering, Christopher B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494657/ https://www.ncbi.nlm.nih.gov/pubmed/23152911 http://dx.doi.org/10.1371/journal.pone.0049481

Ejemplares similares

Potentiation of Thrombin Generation in Hemophilia A Plasma by Coagulation Factor VIII and Characterization of Antibody-Specific Inhibition
por: Doshi, Bhavya S., et al.
Publicado: (2012)

Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A
por: Stem, Christopher, et al.
Publicado: (2021)

In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
por: Almeida-Porada, Graça, et al.
Publicado: (2016)

Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery
por: Almeida-Porada, Graça, et al.
Publicado: (2020)

Effects of Shear Stress on Production of FVIII and vWF in a Cell-Based Therapeutic for Hemophilia A
por: Trevisan, Brady, et al.
Publicado: (2021)

Hemophilia A: an ideal disease to correct in utero
por: Porada, Christopher D., et al.
Publicado: (2014)

Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII
por: Ramamurthy, Ritu M., et al.
Publicado: (2022)

Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A
por: El-Akabawy, Nadia, et al.
Publicado: (2020)

Structure of Blood Coagulation Factor VIII in Complex With an Anti-C2 Domain Non-Classical, Pathogenic Antibody Inhibitor
por: Ronayne, Estelle K., et al.
Publicado: (2021)

Sedimentation Velocity Analytical Ultracentrifugation of Oxidized Recombinant Full-Length Factor VIII
por: Zakas, Philip M., et al.
Publicado: (2020)

Bacterial Production of Recombinant Coagulation Factor VIII Domains
por: Bashar, Saima, et al.
Publicado: (2023)

Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector delivery
por: Brown, Harrison C, et al.
Publicado: (2014)

The Immune Response to the fVIII Gene Therapy in Preclinical Models
por: Patel, Seema R., et al.
Publicado: (2020)

Boosting Hematopoietic Engraftment after in Utero Transplantation through Vascular Niche Manipulation
por: Mokhtari, Saloomeh, et al.
Publicado: (2016)

Generation of an Optimized Lentiviral Vector Encoding a High-Expression Factor VIII Transgene for Gene Therapy of Hemophilia A
por: Johnston, Jennifer M., et al.
Publicado: (2012)

Transplanting FVIII/ET3-secreting cells in fetal sheep increases FVIII levels long-term without inducing immunity or toxicity
por: Rodriguez, Martin, et al.
Publicado: (2023)

Characterization of Naturally-Occurring Humoral Immunity to AAV in Sheep
por: Tellez, Joseph, et al.
Publicado: (2013)

Evaluation of gene delivery strategies to efficiently overexpress functional HLA-G on human bone marrow stromal cells
por: Boura, Joana S, et al.
Publicado: (2014)

The effect of low-frequency electromagnetic field on human bone marrow stem/progenitor cell differentiation
por: Ross, Christina L., et al.
Publicado: (2015)

Human coagulation factor VIII domain-specific recombinant polypeptide expression
por: Choi, Su Jin, et al.
Publicado: (2015)

Pharmacokinetic analysis identifies a factor VIII immunogenicity threshold after AAV gene therapy in hemophilia A mice
por: Lundgren, Taran S., et al.
Publicado: (2022)

Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage
por: Soland, Melisa A., et al.
Publicado: (2013)

Modulation of Human Mesenchymal Stem Cell Immunogenicity through Forced Expression of Human Cytomegalovirus US Proteins
por: Soland, Melisa A., et al.
Publicado: (2012)

Autologous bone marrow-derived MSCs engineered to express oFVIII-FLAG engraft in adult sheep and produce an effective increase in plasma FVIII levels
por: Trevisan, Brady, et al.
Publicado: (2022)

Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies
por: Ramamurthy, Ritu Mahesh, et al.
Publicado: (2022)

Targeting Mesenchymal Stromal Cells/Pericytes (MSCs) With Pulsed Electromagnetic Field (PEMF) Has the Potential to Treat Rheumatoid Arthritis
por: Ross, Christina L., et al.
Publicado: (2019)

Target-Cell-Directed Bioengineering Approaches for Gene Therapy of Hemophilia A
por: Brown, Harrison C., et al.
Publicado: (2018)

Characterization and visualization of murine coagulation factor VIII-producing cells in vivo
por: Hayakawa, Morisada, et al.
Publicado: (2021)

FACTOR VIII COAGULANT ACTIVITY AND FACTOR VIII-LIKE ANTIGEN: INDEPENDENT MOLECULAR ENTITIES
por: Zimmerman, Theodore S., et al.
Publicado: (1973)

Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A
por: Delignat, Sandrine, et al.
Publicado: (2019)

Structure of coagulation factor VIII bound to a patient-derived anti–C1 domain antibody inhibitor
por: Childers, Kenneth C., et al.
Publicado: (2023)

Mechano-covalent protection of coagulation factor VIII by von Willebrand factor
por: Butera, Diego, et al.
Publicado: (2022)

The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics
por: Casademunt, Elisabeth, et al.
Publicado: (2012)

Functional characterization of the immunomodulatory properties of human urine-derived stem cells
por: Wu, Rongpei, et al.
Publicado: (2021)

UNMIX Methods Applied to Characterize Sources of Volatile Organic Compounds in Toronto, Ontario
por: Porada, Eugeniusz, et al.
Publicado: (2016)

Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII
por: Russell, Athena L., et al.
Publicado: (2021)

Enhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction
por: Zakas, Philip M., et al.
Publicado: (2016)

Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID‐19
por: Morabito, Christopher J., et al.
Publicado: (2020)

Evaluating Interaction of Cord Blood Hematopoietic Stem/Progenitor Cells with Functionally Integrated Three‐Dimensional Microenvironments
por: Mokhtari, Saloomeh, et al.
Publicado: (2018)

A HUMAN BONE MARROW MESODERMAL-DERIVED CELL POPULATION WITH HEMOGENIC POTENTIAL
por: Mokhtari, Saloomeh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_14birvvkp5ttnad3clud92s6ut